ESLAW icon

Estrella Immunopharma Warrant
ESLAW

13 hedge funds and large institutions have $2.75M invested in Estrella Immunopharma Warrant in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$9.08K
2
+$6.29K
3
+$4.44K
4
UBS Group
UBS Group
Switzerland
+$266
5
CS
Clear Street
New York
+$22

Top Sellers

1
-$511
2
-$155
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.02M
2
$500K
3
$49K
4
$44K
5
$36K
6
$27K
7
$27K
8
$23K
9
$11K
10
$9K
11
$5K
12
–
13
–